GlassScriptPhysician profile
Benjamin Andrew Cox
NPI 1306104476
$8,511.89
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $756 · 2021: $2,563 · 2022: $1,412 · 2023: $236 · 2024: $2,342 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,933 · Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,932.53 |
| Food and Beverage | $921.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,883.09 | 2019-2025 | |
| Medwest Associates | $1,200.00 | 2021 | |
| Lightbody Medical Technologies INC | $1,098.91 | 2024 | |
| Smith+Nephew, INC. | $103.36 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $96.22 | 2019-2024 | Euflexxa |
| Horizon Therapeutics Plc | $41.72 | 2022 | |
| Fx Shoulder Solutions, INC | $29.39 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.42 | 2024 | Iovera, Zilretta, Exparel |
| Avanos Medical | $22.12 | 2019 | |
| Bioventus LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.